[{"id":"d6f43bf5-4e79-4d99-b785-9354c5c58f6c","acronym":"","url":"https://clinicaltrials.gov/study/NCT06014073","created_at":"2023-08-28T14:08:34.962Z","updated_at":"2024-07-02T16:35:37.560Z","phase":"Phase 1/2","brief_title":"TRAC and Power3 Genes Knock-out Allogeneic CD19-targeting CAR-T Cell Therapy in r/r B-NHL","source_id_and_acronym":"NCT06014073","lead_sponsor":"Chinese PLA General Hospital","biomarkers":" BCL2 • CCND1 • BCL6 • IL6 • TNFA • IL2 • IL10","pipe":" | ","alterations":" CD19 positive • Chr t(11;14) • CCND1 overexpression • BCL6 rearrangement • Chr t(11;14)(q13;q32) • BCL2 rearrangement • CD20 negative","tags":["BCL2 • CCND1 • BCL6 • IL6 • TNFA • IL2 • IL10"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CD19 positive • Chr t(11;14) • CCND1 overexpression • BCL6 rearrangement • Chr t(11;14)(q13;q32) • BCL2 rearrangement • CD20 negative"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e cyclophosphamide • fludarabine IV • ET-901"],"overall_status":"Recruiting","enrollment":" Enrollment 30","initiation":"Initiation: 09/06/2023","start_date":" 09/06/2023","primary_txt":" Primary completion: 09/01/2025","primary_completion_date":" 09/01/2025","study_txt":" Completion: 09/01/2026","study_completion_date":" 09/01/2026","last_update_posted":"2023-09-11"}]